A Smartphone for adjustment of basal insulin dose and for coaching: benefits in terms of glycaemic control for type 2 diabetes patients

被引：0

作者：

Daoudi, A. ^{[1
]}

Joubert, M. ^{[2
]}

Franc, S. ^{[1
,3
]}

Fagour, C. ^{[4
]}

Benhamou, P-Y ^{[5
]}

Reznik, Y. ^{[2
]}

Rodier, M. ^{[6
]}

Boucherie, B. ^{[1
]}

Benamo, E. ^{[7
]}

Schaepelynck, P. ^{[8
]}

Guerci, B. ^{[9
]}

Dardari, D. ^{[1
]}

Penfornis, A. ^{[10
]}

Charpentier, G. ^{[1
,3
]}

机构：

[1] CERITD, Evry, France

[2] CHU Caen, Caen, France

[3] Ctr Hosp Sud Francilien, Corbeil Essonnes, France

[4] CHU Ft De France, Fort De France, France

[5] CHU Grenoble, Grenoble, France

[6] CHU Nimes, Nimes, France

[7] Ctr Hosp Henri Duffaut, Avignon, France

[8] CHU Marseille, Marseille, France

[9] CHU Nancy, Nancy, France

[10] CHU Besancon, Besancon, France

来源：

DIABETOLOGIA | 2013年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1061

引用

页码：S426 / S426

页数：1

共 50 条

[21] Acarbose improves glycaemic control in patients with insulin - Treated type 2 diabetes.
Simpson, H
Robertson-Mackay, F
Montegriffo, E
Fox, C
DIABETOLOGIA, 1999, 42 : A223 - A223
[22] Are older patients with type 2 diabetes and insulin therapy under worse glycaemic control?
Hartung, V.
Reise, K.
Kloos, C.
Keil, S.
Kwetkat, A.
Lehmann, T.
Wolf, G.
Mueller, U. A.
DIABETOLOGIA, 2011, 54 : S263 - S263
[23] Improving glycaemic control in patients with Type 2 diabetes mellitus without insulin therapy
Goudswaard, AN
Stolk, RP
de Valk, HW
Rutten, GEHM
DIABETIC MEDICINE, 2003, 20 (07) : 540 - 544
[24] Is there an association between frequency of self adjustment of insulin dose and metabolic control in patients with diabetes mellitus type 2?
Beluchin, E.
Baez, L.
Mueller, N.
Kloos, C.
Wolf, G.
Mueller, U. A.
DIABETOLOGIA, 2009, 52 : S93 - S93
[25] Lower Basal Insulin Dose - Better Control in Type 1 Diabetes
Strich, David
Balgor, Lucy
Gillis, David
HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 232 - 232
[26] Once weekly basal insulin Fc demonstrated similar glycaemic control to once daily insulin degludec in insulin-naive patients with type 2 diabetes
Bue-Valleskey, J. M.
Kazda, C.
Ma, C.
Chien, J.
Zhang, Q.
Chigutsa, E.
Landschulz, W.
Swan, J.
Haupt, A.
Frias, J.
DIABETOLOGIA, 2022, 65 (SUPPL 1) : S334 - S334
[27] Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes
Patel, S.
Weber, S.
Emser, A.
von Eynatten, M.
Woerle, H. -J.
DIABETOLOGIA, 2011, 54 : S339 - S339
[28] Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes
Madenidou, Anastasia-Vasiliki
Paschos, Paschalis
Karagiannis, Thomas
Katsoula, Anastasia
Athanasiadou, Eleni
Kitsios, Konstantinos
Bekiari, Eleni
Matthews, David R.
Tsapas, Apostolos
ANNALS OF INTERNAL MEDICINE, 2018, 169 (03) : 165 - +
[29] Achievement of glycaemic control by patients initiating basal insulin
Aagren, M.
Wu, N.
Rao, P.
Boulanger, L.
DIABETOLOGIA, 2011, 54 : S418 - S418
[30] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
Seufert, J.
Fritsche, A.
Anderten, H.
Pegelow, K.
Pscherer, S.
Pfohl, M.
DIABETOLOGIA, 2018, 61 : S441 - S441

← 1 2 3 4 5 →